The role of radiation therapy in the management of cutaneous malignancies. Part II: When is radiation therapy indicated?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34116100.
- Also identified by DOI 10.1016/j.jaad.2021.05.057.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Radiation therapy may be performed for a variety of cutaneous malignancies, depending on patient health status, tumor clinical and histologic features, patient preference, and resource availability. Dermatologists should be able to recognize the clinical scenarios in which radiation therapy is appropriate, as this may reduce morbidity, decrease risk of disease recurrence, and improve quality of life. The second article in this 2-part continuing medical education series focuses on the most common indications for radiation therapy in the treatment of basal cell carcinoma, cutaneous squamous cell carcinoma, dermatofibrosarcoma protuberans, Merkel cell carcinoma, Kaposi sarcoma, angiosarcoma, cutaneous lymphoma, melanoma, undifferentiated pleomorphic sarcoma, and sebaceous carcinoma.
Medical subject headings
- Carcinoma, Squamous Cell
- Sarcoma
- Sebaceous Gland Neoplasms
- Skin Neoplasms